The fast-tracked response to Covid-19 has led to a dramatic change in our scope and expectations for trial design. We look at the real-life design and analysis examples you can use in 2022 to accommodate shifts in clinical trial design.
More About The Webinar
2021 was a year of huge change in clinical trials as the implications of the clinical trial innovations fast-tracked in response to Covid-19 has led to a dramatic change in our scope and expectations for trial design.
The huge success and lessons from the Covid-19 vaccines and therapeutics trials over the last two years mean innovations spreading quicker and leading to the evaluation of potential therapeutics faster than ever before.
Platform trials such as RECOVERY and REMAP-CAP have opened up huge possibilities in faster therapy approval and the rapid proliferation of clinical prediction models led to new opportunities and challenges for clinicians.
At the same time, major shifts continue to happen in the analysis of survival trials and the continued growth in adaptive design.
Play the webinar below to see how these changes are impacting clinical trials and what developments may mean for you as a clinical trialist or biostatistician in 2022.